Neomycin and Polymyxin B Sulfates and Dexamethasone - neomycin sulfate, polymyxin b sulfate and dexamethasone
Navigation: NDC > Supplier starting with: F > FALCON PHARMACEUTICALS, LTD.| Field | Value |
|---|---|
| NDC Code: | 61314-630 |
| Proprietary Name: | Neomycin and Polymyxin B Sulfates and Dexamethasone |
| Suffix: | |
| Non-Proprietary Name: | neomycin sulfate, polymyxin b sulfate and dexamethasone |
| Dosage Form: | SUSPENSION |
| Method: | OPHTHALMIC |
| Original Marketing Date: | 21-02-1996 |
| Category Name: | ANDA |
| Application Number: | ANDA062341 |
| Labeler: | FALCON PHARMACEUTICALS, LTD. |
| Substance Name: | DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Active Numerator Strength: | 1; 3.5; 10000 |
| Active Ingredient Unit: | mg/mL; mg/mL; [USP'U]/mL |
| Pharm Classes: | Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient],Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| DEA Schedule: |